Search
Spotlight
Carl Zeiss Case Studies
Clinical
Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina
Articles
Media
Medical World News
Publications
Digital Edition
Subscribe
eNewsletter
Print Subscription
Resources
Sponsored Resources
Zeiss Case Studies
Search
Spotlight
Carl Zeiss Case Studies
Clinical
See All >
Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina
FDA grants orphan status to two Lux products
March 1, 2007
Relevant Topics
The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.
